E-LIB Suche - Ergebnisse für: Pierre, Sabrina - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

P1135: EFFECT OF GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-..:

Pierre, Sabrina ; Heiblig, Maël ; Nourredine, Mikaïl...
HemaSphere. 7 (2023) S3 - p. e62941c4 , 2023

Link: https://doi.org/10.1097/..

2

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid EL...
Digestive and Liver Disease. 53 (2021) 4 - p. 420-426 , 2021

Link: https://doi.org/10.1016/..

3

Methylprednisolone-related liver injury: A descriptive stud..:

Cottin, Judith ; Pierre, Sabrina ; Pizzoglio, Véronique...
Clinics and Research in Hepatology and Gastroenterology. 44 (2020) 5 - p. 662-673 , 2020

Link: https://doi.org/10.1016/..

4

Effets indésirables « graves » du tramadol : bilan 2011–201..:

Moulis, Florence ; Rousseau, Vanessa ; Abadie, Delphine...
Therapies. 72 (2017) 6 - p. 615-624 , 2017

Link: https://doi.org/10.1016/..

5

P1135: EFFECT OF GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-..:

Pierre, Sabrina ; Heiblig, Maël ; Nourredine, Mikaïl...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431117/. , 2023

Link: http://www.ncbi.nlm.nih...

6

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

7

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

8

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

9

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

10

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

11

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.archives-ouv..

12

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

13

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

14

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

15

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid El...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dld.2020.11.036. , 2021

Link: https://hal.science/hal-..

1-15